Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Optimal use of antidepressants: when to act?

× No keyword cloud information.

5 in total

1. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

Authors: Otto Benkert; Armin Szegedi; Michael Philipp; Ralf Kohnen; Claus Heinrich; Anja Heukels; Monique van der Vegte-Senden; Ross A Baker; John H Simmons; Albert-Jan Schutte
Journal: J Clin Psychopharmacol Date: 2006-02 Impact factor: 3.153

2. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

Authors: C A Melfi; A J Chawla; T W Croghan; M P Hanna; S Kennedy; K Sredl
Journal: Arch Gen Psychiatry Date: 1998-12

3. Symptom clusters as predictors of late response to antidepressant treatment.

Authors: Madhukar H Trivedi; David W Morris; Bruce D Grannemann; Susan Mahadi
Journal: J Clin Psychiatry Date: 2005-08 Impact factor: 4.384

4. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

Authors: Armin Szegedi; Matthias J Müller; Ion Anghelescu; Christoph Klawe; Ralf Kohnen; Otto Benkert
Journal: J Clin Psychiatry Date: 2003-04 Impact factor: 4.384

5. The role of the primary care physician in patients' adherence to antidepressant therapy.

Authors: E H Lin; M Von Korff; W Katon; T Bush; G E Simon; E Walker; P Robinson
Journal: Med Care Date: 1995-01 Impact factor: 2.983

5 in total

3 in total

Optimal use of antidepressants: when to act?

1. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

2. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

3. Symptom clusters as predictors of late response to antidepressant treatment.

4. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

5. The role of the primary care physician in patients' adherence to antidepressant therapy.

1. The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice.

2. The Interpeduncular-Ventral Hippocampus Pathway Mediates Active Stress Coping and Natural Reward.

3. 5-HT₃ receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders.